Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer
Abstract Background Bladder cancer has numerous genomic features that are potentially actionable by targeted agents. Nevertheless, both pre-clinical and clinical research using molecular targeted agents have been very limited in bladder cancer. Results We created the Genomics of Drug Sensitivity in...
Saved in:
Main Authors: | Adnan Ahmad Ansari (Author), Inkeun Park (Author), Inki Kim (Author), Sojung Park (Author), Sung-Min Ahn (Author), Jae-lyun Lee (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2018-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Localized amyloidosis of the urinary bladder, clinically masquerading as bladder cancer
by: DeSouza Maria, et al.
Published: (2008) -
Bladder Cancer Management of NMI and Muscle-Invasive Cancer
Published: (2017) -
Anlotinib Enhances the Therapeutic Effect of Bladder Cancer with GSDMB Expression: Analyzed from TCGA Bladder Cancer Database & Mouse Bladder Cancer Cell Line
by: Wang C, et al.
Published: (2023) -
Bladder Cancer From Basic Science to Robotic Surgery
Published: (2012) -
miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer
by: Nordentoft Iver, et al.
Published: (2012)